Adenanthin targets peroxiredoxin I and II to induce differentiation of leukemic cells
2012 · Nature Chemical Biology · 219 citations
https://doi.org/10.1038/nchembio.935
C
Claim or correct this author profile
Claim this profile or suggest corrections to the name, affiliation, bio, photo, or paper titles. Approved changes appear as verified CitedEvidence overlays.
43
Papers
1.1K
Citations
15
h-index
19
i10-index
Chuanxu Liu is an academic researcher from Chinese Academy of Medical Sciences & Peking Union Medical College. The author has contributed to research in topics: Lymphoma Diagnosis and Treatment & Retinoids in leukemia and cellular processes & Immune Cell Function and Interaction. The author has an h-index of 15, co-authored 37 publications.
ORCID: 0000-0002-3125-9547Papers by this author
worksWP1130 reveals USP24 as a novel target in T-cell acute lymphoblastic leukemia
2019 · Cancer Cell International · 33 citations
https://doi.org/10.1186/s12935-019-0773-6
Targeting Bcl-xL is a potential therapeutic strategy for extranodal NK/T cell lymphoma
2023 · iScience · 7 citations
https://doi.org/10.1016/j.isci.2023.107369
ZCL-082, a boron-containing compound, induces apoptosis of non-Hodgkin's lymphoma via targeting p90 ribosomal S6 kinase 1/NF-κB signaling pathway
2021 · Chemico-Biological Interactions · 4 citations
https://doi.org/10.1016/j.cbi.2021.109770
Research topics
topicsChat about Author
Papers
Chat
Click to start Chat